REGEN-COV: Antibody therapy shows long-term protection against COVID-19
Regeneron Pharmaceuticals said on Monday a single dose of its antibody cocktail reduced the risk… Read More
4 years ago
Regeneron Pharmaceuticals said on Monday a single dose of its antibody cocktail reduced the risk… Read More
People with mild-to-moderate COVID-19 who were treated with a monoclonal antibody "cocktail" had lower hospitalization… Read More
A two-drug antibody cocktail from Regeneron Pharmaceuticals called REGEN-COV prevents COVID-19 in people exposed to… Read More
The two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower… Read More